“…Studies conducted in recent years have reported that increased intestinal permeability may be associated with many systemic, autoimmune, metabolic, neurological, psychiatric, and dermatological conditions. The diseases that have been subjected to investigation regarding the association between zonulin levels and intestinal permeability include type 1 diabetes mellitus, rheumatoid arthritis, vitiligo, celiac disease, inflammatory bowel diseases, systemic lupus erythematosus, Alzheimer’s disease, multiple sclerosis, schizophrenia, psoriasis, rosacea, dermatitis herpetiformis, atopic dermatitis, and alopecia areata 2 3 4 5 6 7 8 9 10 11 . The zonulin protein regulates tight junction permeability between intestinal absorptive cells.…”